Keylika
Keylika focuses on the intersection of drug discovery and drug delivery, utilizing AI-enabled drug design and nanotechnology to create innovative therapies. Their flagship product is the world's first Rx skin patch for treating iron deficiency anemia (IDA), which allows for direct absorption of iron into the bloodstream, bypassing gastrointestinal side effects. This solution combines the convenience of oral iron with the efficacy of intravenous iron, addressing a significant unmet medical need affecting millions globally. Keylika's approach aims to improve patient compliance and clinical outcomes, positioning them as a leader in the transdermal drug delivery market.
Keylika
Keylika focuses on the intersection of drug discovery and drug delivery, utilizing AI-enabled drug design and nanotechnology to create innovative therapies. Their flagship product is the world's first Rx skin patch for treating iron deficiency anemia (IDA), which allows for direct absorption of iron into the bloodstream, bypassing gastrointestinal side effects. This solution combines the convenience of oral iron with the efficacy of intravenous iron, addressing a significant unmet medical need affecting millions globally. Keylika's approach aims to improve patient compliance and clinical outcomes, positioning them as a leader in the transdermal drug delivery market.